We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

62 hedge funds and large institutions have $704M invested in Akcea Therapeutics Inc in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 16 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $13.1M | Put options by funds: $8.11M

38% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 16

5% less funds holding

Funds holding: 65 → 62 (-3)

14% less capital invested

Capital invested by funds: $817M → $704M (-$113M)

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

Holders
62
Holders Change
-3
Holders Change %
-4.62%
% of All Funds
1.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
16
Closed
14
Calls
$13.1M
Puts
$8.11M
Net Calls
+$5.03M
Net Calls Change
+$33.1M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$14.7M
2
Citadel Advisors
Citadel Advisors
Florida
+$3.27M
3
BlackRock
BlackRock
New York
+$3.19M
4
First Trust Advisors
First Trust Advisors
Illinois
+$2.09M
5
MFAM
Motley Fool Asset Management
Virginia
+$1.46M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$18.4M
2
AA
ALPS Advisors
Colorado
-$5.31M
3
EC
EcoR1 Capital
California
-$3.23M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
-$1.93M
5
Deutsche Bank
Deutsche Bank
Germany
-$1.06M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$403M +$14.7M +523,834 +4%
BB
2
BB Biotech
Switzerland
$71.9M – – –
BlackRock
3
BlackRock
New York
$60.6M +$3.19M +113,784 +6%
Vanguard Group
4
Vanguard Group
Pennsylvania
$37.5M +$1.45M +51,562 +4%
Wellington Management Group
5
Wellington Management Group
Massachusetts
$33.7M -$18.4M -655,491 -37%
EC
6
EcoR1 Capital
California
$19.3M -$3.23M -115,377 -15%
BG
7
Bellevue Group
Switzerland
$13.8M +$1.12M +39,800 +10%
State Street
8
State Street
Massachusetts
$9.88M -$783K -27,931 -8%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$6.78M +$447K +15,950 +8%
Citadel Advisors
10
Citadel Advisors
Florida
$6.19M +$3.27M +116,623 +132%
Northern Trust
11
Northern Trust
Illinois
$5.73M -$59.9K -2,137 -1%
Morgan Stanley
12
Morgan Stanley
New York
$5.56M +$634K +22,635 +14%
SC
13
Sculptor Capital
New York
$3.23M – – –
Charles Schwab
14
Charles Schwab
California
$2.51M +$298K +10,634 +15%
AGA
15
Altrinsic Global Advisors
Connecticut
$2.27M -$561K -20,000 -21%
First Trust Advisors
16
First Trust Advisors
Illinois
$2.25M +$2.09M +74,494 New
Bank of New York Mellon
17
Bank of New York Mellon
New York
$1.84M +$214K +7,635 +14%
MFAM
18
Motley Fool Asset Management
Virginia
$1.57M +$1.46M +52,217 New
Goldman Sachs
19
Goldman Sachs
New York
$1.52M +$105K +3,734 +8%
SSA
20
Schonfeld Strategic Advisors
New York
$1.41M +$1.31M +46,800 New
ProShare Advisors
21
ProShare Advisors
Maryland
$953K -$138K -4,914 -13%
Parallax Volatility Advisers
22
Parallax Volatility Advisers
California
$934K +$342K +12,218 +65%
Swiss National Bank
23
Swiss National Bank
Switzerland
$913K +$56.1K +2,000 +7%
TA
24
Teachers Advisors
New York
$878K +$10.4K +371 +1%
AllianceBernstein
25
AllianceBernstein
Tennessee
$877K +$44.9K +1,600 +6%
1
2 3 4

AKCA Hedge Fund Activity: Q4 2018 in Review

62 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q4 2018, worth a combined $704M — down 14% from $817M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of AKCA and 11 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 22 added.

The largest buyer was Fidelity Investments, adding an estimated $14.7M. The largest seller was Wellington Management Group, cutting an estimated $18.4M.

  • 62 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q4 2018, down from 65 in Q3 2018.
  • Funds reported $704M of Akcea Therapeutics Inc stock for Q4 2018, down 14% quarter-over-quarter.
  • 11 funds opened new Akcea Therapeutics Inc positions in Q4 2018 and 14 closed out, a net change of -3 holders.
  • The largest Akcea Therapeutics Inc buyer in Q4 2018 was Fidelity Investments, an estimated $14.7M added.
  • The largest Akcea Therapeutics Inc seller in Q4 2018 was Wellington Management Group, an estimated $18.4M sold.

Based on aggregated 13F filings for Q4 2018.